Bartsch, Rupert https://orcid.org/0000-0002-4384-6917
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 19 February 2024
Accepted: 14 May 2024
First Online: 4 June 2024
Conflict of interest
: R. Bartsch reports the following conflicts of interest: Advisory Role: Astra-Zeneca, Celgene, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Stemline; Lecture Honoraria: Accord, Astra-Zeneca, BMS, Celgene, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Stemline; Research Support: Daiichi, MSD, Novartis, Roche.